Clinical Trial Update: Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia) [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating certolizumab pegol (Cimzia) in rheumatoid arthritis have been posted. The update reports the completed study findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: Nathan Wei, MD, FACP, FACR: | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2014-04-08